Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Feb 21;25(7):837-847.
doi: 10.3748/wjg.v25.i7.837.

Nutrient drink test: A promising new tool for irritable bowel syndrome diagnosis

Affiliations
Randomized Controlled Trial

Nutrient drink test: A promising new tool for irritable bowel syndrome diagnosis

Fermin Estremera-Arevalo et al. World J Gastroenterol. .

Abstract

Background: Irritable bowel syndrome (IBS) is a highly prevalent condition. It is diagnosed on the basis of chronic symptoms after the clinical and/or investigative exclusion of organic diseases that can cause similar symptoms. There is no reproducible non-invasive test for the diagnosis of IBS, and this raises diagnostic uncertainty among physicians and hinders acceptance of the diagnosis by patients. Functional gastrointestinal (GI) syndromes often present with overlapping upper and lower GI tract symptoms, now believed to be generated by visceral hypersensitivity. This study examines the possibility that, in IBS, a nutrient drink test (NDT) provokes GI symptoms that allow a positive differentiation of these patients from healthy subjects.

Aim: To evaluate the NDT for the diagnosis of IBS.

Methods: This prospective case-control study compared the effect of two different nutrient drinks on GI symptoms in 10 IBS patients (patients) and 10 healthy controls (controls). The 500 kcal high nutrient drink and the low nutrient 250 kcal drink were given in randomized order on separate days. Symptoms were assessed just before and at several time points after drink ingestion. Global dyspepsia and abdominal scores were derived from individual symptom data recorded by two questionnaires designed by our group, the upper and the general GI symptom questionnaires, respectively. Psycho-social morbidity and quality of life were also formally assessed. The scores of patients and controls were compared using single factor analysis of variance test.

Results: At baseline, IBS patients compared to controls had significantly higher levels of GI symptoms such as gastro-esophageal reflux (P = 0.05), abdominal pain (P = 0.001), dyspepsia (P = 0.001), diarrhea (P = 0.001), and constipation (P = 0.001) as well as higher psycho-social morbidity and lower quality of life. The very low incidence of GI symptoms reported by control subjects did not differ significantly for the two test drinks. Compared with the low nutrient drink, IBS patients with the high nutrient drink had significantly more dyspeptic symptoms at 30 (P = 0.014), 45 (P = 0.002), 60 (P = 0.001), and 120 min (P = 0.011). Dyspeptic symptoms triggered by the high nutrient drink during the first 120 min gave the best differentiation between healthy controls and patients (area under receiver operating curve of 0.915 at 45 min for the dyspepsia score). Continued symptom monitoring for 24 h did not enhance separation of patients from controls.

Conclusion: A high NDT merits further evaluation as a diagnostic tool for IBS.

Keywords: Dyspepsia; Irritable bowel syndrome; Non-invasive; Nutrient drink test; Screening.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: None of the authors have conflicts of interest to be declared.

Figures

Figure 1
Figure 1
Flowchart of patients recruitment. Left column shows flow of inclusion and right column the excluded patients. IBS: Irritable bowel syndrome; IBSSS: Irritable bowel severity scoring system; FD: Functional dyspepsia.
Figure 2
Figure 2
Global dyspepsia in irritable bowel syndrome patients and control subjects after the nutrient drink test. Global dyspepsia mean Likert score in IBS patients and control subjects was measured for the first 2 h after the two drinks. Statistically significant differences are shown in the graph (aP < 0.05). IBS: Irritable bowel syndrome.
Figure 3
Figure 3
Abdominal symptoms in IBS patients and control subjects after the nutrient drink test. Abdominal mean Likert score in IBS patients and control subjects were measured after the two test drinks over 24 h. Statistically significant differences are shown in the graph (aP < 0.05). IBS: Irritable bowel syndrome.
Figure 4
Figure 4
Sensitivity and specificity of the nutrient drink test. Receiver operating characteristic curves for Global Dyspepsia (upper) and Global Abdominal (lower) scores obtained at the different time points after the high nutrient drink are represented.

Similar articles

References

    1. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: A meta-analysis. Clin Gastroenterol Hepatol. 2012;10:712–721.e4. - PubMed
    1. Ford AC, Talley NJ, Walker MM, Jones MP. Increased prevalence of autoimmune diseases in functional gastrointestinal disorders: Case-control study of 23471 primary care patients. Aliment Pharmacol Ther. 2014;40:827–834. - PubMed
    1. Badia X, Mearin F, Balboa A, Baró E, Caldwell E, Cucala M, Díaz-Rubio M, Fueyo A, Ponce J, Roset M, Talley NJ. Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics. 2002;20:749–758. - PubMed
    1. Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel Disorders. Gastroenterology. 2016;pii:S0016–5085(16)00222-5. - PubMed
    1. Ford AC, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology. 2013;145:1262–70.e1. - PubMed

Publication types